Last reviewed · How we verify
Mobile Terminal Based Management and Platelet Reactivity Modified Drug Regulation of Stroke Secondary Prevention
The investigators want to verify whether mobile application based on stroke strengthen prevention management is more effective than traditional management model or open stroke management platform. Whole blood-impedance based platelet aggregation(WBA) method and VerifyNow detected by aspirin or clopidogrel responsiveness will provide individualized anti-platelet drug selection. Endpoint event is defined as stroke death or relapse. Primary measure outcomes are change of the stroke recurrence rate and mortality after secondary prevention.
Details
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 400 |
| Start date | 2016-01 |
| Completion | 2018-12 |
Conditions
- Stroke
Interventions
- Mobile terminal
- traditional management
- website platform management
Primary outcomes
- change of the stroke recurrence rate — 2 years stroke recurrence rate
After secondary prevention
Countries
China